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A 53-year-old, postmenopausal, female never smoker of Caucasian descent, presented with a palpable mass in her left 
breast discovered during self-examination. She had not under-
gone screening mammography for the last 3 years before presen-
tation and had no family history of breast or ovarian cancer. On 
palpation, the mass was solid and firmly attached to the thoracic 
wall. Mammography of the left breast indicated the presence of a 
multilobular mass measuring 3.1 × 2.8 cm in the lower-inner quad-
rant and a second, smaller lesion in the same quadrant measuring 
1.1 × 1.2 cm (Fig. 1A, mediolateral oblique [MLO] mammogra-
phy). Mammography of the right breast revealed the presence of 
a third lesion, measuring 1.3 × 0.9 cm in the upper-outer quad-
rant, (Fig. 1B,/MLO mammography). Despite the absence of 
spiculated margins and microcalcifications, all three lesions were 
labeled as Breast Imaging and Reporting Data System category 
5 tumors. No enlarged axillar lymph nodes were observed during 
clinical and mammographic examination. No chest radiograph 
was performed at initial presentation. A subsequent ultrasound-
guided biopsy of all three lesions revealed massive infiltration of 
the mammary gland by a poorly differentiated carcinoma com-
prising large and medium-size cells with hyperdense nuclei (Fig. 
2A,B), that stained negative for mammοglobin, estrogen and pro-
gesterone receptors, but positive for thyroid transcription factor 
1 (TTF1; Fig. 2C). The patient underwent computed tomogra-
phy scan of the thorax that revealed the presence of a previously 
unidentified mass in the left lung that extended from the left apex 
to the left hilar region with lobular margins (Fig. 3A). The mass, 
that measured 9 × 9 × 6 cm, encapsulated the upper lobar branch 
of the left main pulmonary artery, restricting its lumen to 4 mm 
(Fig. 3D, long black arrows) and was in close proximity with the 
aortic arch, infiltrating the mediastinal pleura, the left subcla-
vian artery, and the left oesophageal wall (Fig. 3A,B, short black 
arrows). Enlarged paratracheal, subcarinal, and left hilar lymph 
nodes were also noted (Fig. 3B, short black arrows). At the same 
time, multiple nodular lesions were observed in the left thoracic 
wall, in front of the major pectoralis muscle, with the largest one 
corresponding to the fixed breast mass that was reported as the 
presenting sign of the patient (Fig. 3C, white arrows). A subse-
quent computed tomography-guided biopsy of the thoracic mass 
confirmed the diagnosis of a poorly differentiated adenocarci-
noma of the lung with a high mitotic index and a positive stain for 
TTF1. Morphological and immunohistochemical features of the 
breast lesions were consistent with metastases from the primary 
lung adenocarcinoma. Mutation analysis of the tumor specimen 
revealed no activating mutation of the EGFR gene and fluores-
cence in situ hybridization analysis with break-apart probes for 
the ALK gene was negative for the presence of an ALK rearrange-
ment. On the basis of these findings, the patient received first-line 
chemotherapy encompassing paclitaxel carboplatin and bevaci-
zumab. After three cycles of chemotherapy, reevaluation showed 
progressive disease in both the primary tumor and the metastatic 
lesions to the breast. The patient is currently receiving second-
line chemotherapy with pemetrexed.
DISCUSSION
Mammary gland metastases from extramammary malig-
nant neoplasms are rare, accounting for only approximately 2% 
of breast tumors.1 The most common primary malignancy is a 
contralateral breast carcinoma, followed by leukemia and lym-
phoma.1 Lung cancer represents a far less common tumor to 
metastasize to the breasts, with sporadic reports on lung adeno-
carcinoma2,3 (one in a male patient),3 large-cell neuroendocrine 
carcinoma,3 squamous-cell carcinoma,4 and small-cell lung can-
cer.1,5 Moreover, in many cases, detection of metastases to the 
breast from solid tumors comes at a late clinical stage, when 
patients are already known to have systemic, widespread dis-
ease.1 In the largest series reported to date, Hajdu et al.1 described 
51 patients with metastasis to the breast from various primary 
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tumors over a period of 10 years, among which six patients with 
lung cancer (five with small-cell lung cancer and only one with 
non–small-cell lung cancer). Of note, the breast metastases were 
the first manifestation of disease in only 16 cases, including all 
six cases of lung cancer. To our knowledge, our case is the first 
one of confirmed bilateral mammary gland metastases that were 
the presenting sign of non–small-cell lung cancer. Our patient has 
chemoresistant disease, which confirms the dismal prognosis of 
patients with mammary gland metastases.1 Despite being a never 
smoker, her tumor did not harbor any activating mutations in 
the EGFR gene or rearrangements of the ALK proto-oncogene. 
Future analysis will include testing for ROS1 or RET mutations 
in an effort to identify a driver genetic aberration in this patient.
Although on mammography metastatic lesions are usually 
characterized by multifocality and absence of axillar lymphade-
nopathy, as in our case, differential diagnosis between primary 
multifocal—or even bilateral—breast cancer and metastatic 
disease may prove challenging. In controversial cases, immu-
nohistochemistry, and especially the use of the marker TTF1, 
allows a more confident differentiation between a primary breast 
adenocarcinoma and metastasis from primary lung adenocar-
cinoma. To our knowledge, TTF1 positivity has never been 
described in primary breast tumors, whereas it represents a valid 
diagnostic marker for primary adenocarcinomas of the lung 
(specificity: 95–97%) and primary thyroid carcinomas.1,2 For 
our analysis, we used the isotype IgG1 kappa monoclonal mouse 
antibody (Clone 8G7G3/1, Dako Pharmaceuticals), which iden-
tifies the 40 kDa TTF1 band in nuclear extracts or whole cell 
FIGURE 2.  A and B, Hematoxylin-Eosin staining of the left 
breast tumor showing massive infiltration of the mammary 
gland by a poorly differenetiated carcinoma comprising 
medium and large-size cells with hyperdense nuclei  (A, mag-
nification X 10; B, magnification X 100). C, Strong positive 
staining of the tumor cells for thyroid transcription factor 1 
(TTF1) (magnification X 40).
FIGURE 1.  Mammographic images of the left (A) and right 
(B) breast. Mediolateral oblique view.
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lysates of TTF1-positive cell lines of rat, mouse and man and 
is reported to demonstrate an excellent specificity.6 TTF1 is not 
recommended for routine immunohistochemical testing of breast 
tumors. Nevertheless, in controversial cases, it can be used along-
side with mammoglobin, hormone receptor and HER2/neu stain-
ing to determine the site of origin between the lung and the breast.
Although not routinely recommended as part of the 
diagnostic work-up of early breast cancer by the European 
Society for Medical Oncology guidelines,7 radiograph of the 
thorax is included in the National Comprehensive Cancer 
Network guidelines8 and remains an indispensable tool for 
the initial assessement in every patient with suspected malig-
nancy, even in asymptomatic patients with nonsmoking his-
tory, as in our case. Although chest radiograph itself cannot 
safely differentiate between breast cancer metastatic to the 
lung and vice versa, radiologic evidence of a lung mass with 
mediastinal lymphadenopathy provides further support to the 
metastatic nature of breast lesions. Accurate diagnosis is of 
paramount importance, because it may obviate the need for 
unnecessary, extensive surgical procedures, which have little 
to offer in cases of widespread metastatic disease.
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FIGURE 3.  Computed tomography scan of the thorax showing the left lung mass extending from the left apex to the left hilar 
region with lobular margins (A, coronal axis), the enlarged paratracheal, subcarinal and left hilar lymph nodes (B, vertical axis), 
the left breast mass fixed on the left thoracic wall (C, vertical axis, white arrow), the encapsulation of the upper lobar branch of 
the left main pulmonary artery (D, vertical axis, long black arrow), and the same image in soft-tissue algorithm (E, vertical axis).
